Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2026-01-05 @ 5:23 PM
Study NCT ID:
NCT02635035
Status:
COMPLETED
Last Update Posted:
2021-11-16
First Post:
2015-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT
Sponsor:
NYU Langone Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11
Start Date Type:
None
Primary Completion Date:
2019-01-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-18
First Submit QC Date:
None
Study First Post Date:
2015-12-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-03-11
Results First Submit QC Date:
None
Results First Post Date:
2021-11-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-18
Last Update Post Date:
2021-11-16
Last Update Post Date Type:
ACTUAL